| A bacterial cysteine protease effector protein interferes with photosynthesis to suppress plant innate immune responses JJ Rodríguez‐Herva, P González‐Melendi, R Cuartas‐Lanza, ... Cellular Microbiology 14 (5), 669-681, 2012 | 169 | 2012 |
| CD83: activation marker for antigen presenting cells and its therapeutic potential Z Li, X Ju, PA Silveira, E Abadir, WH Hsu, DNJ Hart, GJ Clark Frontiers in immunology 10, 1312, 2019 | 144 | 2019 |
| Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells KP Micklethwaite, K Gowrishankar, BS Gloss, Z Li, JA Street, L Moezzi, ... Blood, The Journal of the American Society of Hematology 138 (16), 1391-1405, 2021 | 117 | 2021 |
| Immunotherapy for hepatocellular carcinoma: From basic research to clinical use YP Hong, ZD Li, P Prasoon, Q Zhang World journal of hepatology 7 (7), 980, 2015 | 65 | 2015 |
| Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin J Zhou, R Teng, C Xu, Q Wang, J Guo, C Xu, Z Li, S Xie, J Shen, L Wang Oncology reports 30 (4), 1622-1630, 2013 | 54 | 2013 |
| The analysis of CD83 expression on human immune cells identifies a unique CD83+-activated T cell population X Ju, PA Silveira, WH Hsu, Z Elgundi, R Alingcastre, ND Verma, ... The Journal of Immunology 197 (12), 4613-4625, 2016 | 44 | 2016 |
| CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma Z Li, X Ju, K Lee, C Clarke, JL Hsu, E Abadir, CE Bryant, S Pears, ... haematologica 103 (4), 655, 2018 | 33 | 2018 |
| Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant DJ Gottlieb, LE Clancy, B Withers, HM McGuire, F Luciani, M Singh, ... Clinical & translational immunology 10 (3), e1249, 2021 | 30 | 2021 |
| A circulating tumor cell cluster-based model for tumor metastasis (Hypothesis) Y Hong, Z Li, Q Zhang Oncology letters 12 (6), 4891-4895, 2016 | 23 | 2016 |
| The relationship between Lin28 and the chemotherapy response of gastric cancer RY Teng, JC Zhou, ZN Jiang, CY Xu, ZD Li, QC Wang, CP Xu, JF Guo, ... OncoTargets and therapy, 1341-1345, 2013 | 22 | 2013 |
| Development of CAR T cell therapy in children—A comprehensive overview M Boettcher, A Joechner, Z Li, SF Yang, P Schlegel Journal of Clinical Medicine 11 (8), 2158, 2022 | 17 | 2022 |
| Rapidly expanded partially HLA DRB1–matched fungus-specific T cells mediate in vitro and in vivo antifungal activity G Castellano-González, HM McGuire, F Luciani, LE Clancy, Z Li, S Avdic, ... Blood Advances 4 (14), 3443-3456, 2020 | 12 | 2020 |
| Comparison of complete polyprotein sequences of two isolates of salmon alphavirus (SAV) type I and their behaviour in a salmonid cell line I Matejusova, K Lester, Z Li, J Bravo, F Bland, B Collet Archives of virology 158, 2143-2146, 2013 | 11 | 2013 |
| New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer J Zhou, JF Guo, RY Teng, QC Wang, J Wang, Q Wei, ZD Li, JG Shen, ... OncoTargets and therapy, 5041-5047, 2016 | 6 | 2016 |
| Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody Z Li, E Abadir, K Lee, C Clarke, CE Bryant, W Cooper, G Pietersz, ... Clinical & translational immunology 9 (7), e1156, 2020 | 3 | 2020 |
| Treatment Method DNJ Hart, GJ Clark, EA Abadir, X Ju, Z Li US Patent App. 16/646,745, 2020 | 2 | 2020 |
| Evaluation of anti-CD83 monoclonal antibodies for the diagnosis and treatment of Hodgkin lymphoma and mantle cell lymphoma Z Li University of Sydney, 2020 | | 2020 |
| CD83 is a new potential biomarker and therapeutic target for lymphoma X Ju, Z Li, E Abadir, K Lee, C Clarke, J Hsu, C Bryant, S Pears, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 1679-1679, 2019 | | 2019 |
| Anti-Human CD83 immune suppression targets activated DC and induces tolerance X Ju, P Silveira, WH Hsu, Z Li, Z Elgundi, R Alingcastre, N Verma, ... EUROPEAN JOURNAL OF IMMUNOLOGY 48, 75-75, 2018 | | 2018 |
| CD83 is a leading therapeutic target in Hodgkin and mantle cell lymphoma E Abadir, K Lee, Z Li, C Clarke, WA Cooper, RE Gasiororwski, X Ju, ... Pathology 50, S101, 2018 | | 2018 |
Pablo A. SilveiraANZAC Research InstituteVerified email at sydney.edu.au
